Literature DB >> 1329640

In vitro activities of penciclovir and acyclovir against herpes simplex virus types 1 and 2.

A Weinberg1, B J Bate, H B Masters, S A Schneider, J C Clark, C G Wren, J A Allaman, M J Levin.   

Abstract

Penciclovir (PCV) and acyclovir are acyclic guanine analogs which inhibit herpes simplex virus (HSV) DNA polymerase. Their 50% infective doses were 0.5 to 0.8 microgram/ml for clinical isolates of HSV-1 and 1.3 to 2.2 micrograms/ml for HSV-2. Furthermore, HSV-infected cultures receiving 2-h pulses of PCV had 2- to 50-fold less HSV than acyclovir-treated cultures, consistent with the prolonged intracellular half-life of PCV triphosphate.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1329640      PMCID: PMC192432          DOI: 10.1128/AAC.36.9.2037

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  5 in total

1.  Antiherpesvirus activity of 9-(4-hydroxy-3-hydroxymethylbut-1-yl) guanine (BRL 39123) in animals.

Authors:  M R Boyd; T H Bacon; D Sutton
Journal:  Antimicrob Agents Chemother       Date:  1988-03       Impact factor: 5.191

2.  Rapid herpes simplex virus susceptibility testing using an enzyme-linked immunosorbent assay performed in situ on fixed virus-infected monolayers.

Authors:  G P Rabalais; M J Levin; F E Berkowitz
Journal:  Antimicrob Agents Chemother       Date:  1987-06       Impact factor: 5.191

3.  Mode of action, toxicity, pharmacokinetics, and efficacy of some new antiherpesvirus guanosine analogs related to buciclovir.

Authors:  A Larsson; K Stenberg; A C Ericson; U Haglund; W A Yisak; N G Johansson; B Oberg; R Datema
Journal:  Antimicrob Agents Chemother       Date:  1986-10       Impact factor: 5.191

4.  Mode of action of 9-(4-hydroxy-3-hydroxymethylbut-1-yl)guanine (BRL 39123) against herpes simplex virus in MRC-5 cells.

Authors:  R A Hodge; R M Perkins
Journal:  Antimicrob Agents Chemother       Date:  1989-02       Impact factor: 5.191

5.  Antiherpesvirus activity of 9-(4-hydroxy-3-hydroxy-methylbut-1-yl)guanine (BRL 39123) in cell culture.

Authors:  M R Boyd; T H Bacon; D Sutton; M Cole
Journal:  Antimicrob Agents Chemother       Date:  1987-08       Impact factor: 5.191

  5 in total
  15 in total

Review 1.  Current recommendations for the treatment of genital herpes.

Authors:  D T Leung; S L Sacks
Journal:  Drugs       Date:  2000-12       Impact factor: 9.546

2.  IL-36γ induces a transient HSV-2 resistant environment that protects against genital disease and pathogenesis.

Authors:  Jameson K Gardner; Melissa M Herbst-Kralovetz
Journal:  Cytokine       Date:  2018-08-15       Impact factor: 3.861

3.  Frequency of acyclovir-resistant herpes simplex virus in clinical specimens and laboratory isolates.

Authors:  Y K Shin; G Y Cai; A Weinberg; J J Leary; M J Levin
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

4.  In vitro activity of penciclovir against clinical isolates of acyclovir-resistant and foscarnet-resistant herpes simplex virus.

Authors:  S Safrin; L Phan
Journal:  Antimicrob Agents Chemother       Date:  1993-10       Impact factor: 5.191

Review 5.  Famciclovir: a review of its use in herpes zoster and genital and orolabial herpes.

Authors:  Dene Simpson; Katherine A Lyseng-Williamson
Journal:  Drugs       Date:  2006       Impact factor: 9.546

6.  Susceptibilities of herpes simplex viruses to penciclovir and acyclovir in eight cell lines.

Authors:  Jeffry J Leary; Robert Wittrock; Robert T Sarisky; Adriana Weinberg; Myron J Levin
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

Review 7.  Famciclovir. A review of its pharmacological properties and therapeutic efficacy in herpesvirus infections.

Authors:  C M Perry; A J Wagstaff
Journal:  Drugs       Date:  1995-08       Impact factor: 9.546

8.  Comparative activity of penciclovir and acyclovir in mice infected intraperitoneally with herpes simplex virus type 1 SC16.

Authors:  D Sutton; M R Boyd
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

9.  Safety of famciclovir in patients with herpes zoster and genital herpes.

Authors:  R Saltzman; R Jurewicz; R Boon
Journal:  Antimicrob Agents Chemother       Date:  1994-10       Impact factor: 5.191

Review 10.  Aciclovir. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  A J Wagstaff; D Faulds; K L Goa
Journal:  Drugs       Date:  1994-01       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.